SCHEMBL2115405

SCHEMBL2115405

CC(C)c1ccc(C(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.68
KDM4E B2RXH2 1/20 0.68
RAB9A P51151 6/20 0.66
SMN1; SMN2 Q16637 5/20 0.66
NPC1 O15118 5/20 0.66
EGFR P00533 1/20 0.65
ERBB2 P04626 1/20 0.65
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
NT5E P21589 1/20 0.60
MAPK1 P28482 1/20 0.60
ENPP3 O14638 1/20 0.60
ENPP1 P22413 1/20 0.60
ALDH1A1 P00352 1/20 0.59
TDP1 Q9NUW8 1/20 0.58
PRMT1 Q99873 1/20 0.57
CASP3 P42574 1/20 0.57
SENP8 Q96LD8 1/20 0.57
SENP7 Q9BQF6 1/20 0.57
SENP6 Q9GZR1 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17660198 1.00 LMNA (0.68) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL23844169 0.93 LMNA (0.76) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL611657 0.87 NPC1 (0.76) LMNARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL9767723 0.87 NPC1 (0.76) LMNARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL10939703 0.87 NPC1 (0.76) LMNARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL26915306 0.86 LMNA (0.68) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL6555841 0.86 LMNA (0.68) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL8461727 0.86 LMNA (0.68) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL12218081 0.86 RAB9A (0.76) LMNAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL94369 0.85 LMNA (0.66) LMNAKDM4ERAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120225869-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2012-09-06 US disclosed
US-8158634-B2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC (BM) 2012-04-17 US disclosed
CN-102241680-A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC 2011-11-16 CN disclosed
CN-101048408-B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC 2011-07-06 CN disclosed
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2009-10-01 US disclosed
CN-101048408-A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC (BM) 2007-10-03 CN disclosed
EP-1807429-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM, LLC (BM) 2007-07-18 EP disclosed
WO-2006047516-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225869-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY CNR1, CNR2, FAAH LMNA 2549/4885KDM4E 1763/4885RAB9A 902/4885
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY CNR1, CNR2, FAAH LMNA 2549/4885KDM4E 1763/4885RAB9A 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.